AG-1002

N/A

Report date: 2026/02/03 20:00:14

Base Information

Drug NameAG-1002
Drug Alias NameHuman adipose - derived mesenchymal stem cells(Beijing Aige Stem Cell Technology)人脂肪间充质干细胞注射液人脂肪间充质干细胞（北京瑷格干细胞科技）AG1002
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsScleroderma, Localized
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Aige Stem Cell Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Aige Stem Cell Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsScleroderma, Localized
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A